MedTrace Logo

Taekwondo for Axial Spondyloarthritis

NCT06823726 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-03-25

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if Taekwondo training works to help adults with ankylosing spondylitis and axial spondyloarthritis. It will also learn about the safety of Taekwondo training for these adults.

The main questions are as follows:

* Will Taekwondo training affect disease activity, functional improvement, and quality of life?
* Will there be a difference between adults who participate in Taekwondo training and adults who continue with their usual treatment?
* Is Taekwondo training safe for adults with ankylosing spondylitis and axial spondyloarthritis, and will it be an appropriate exercise for these adults?
* Is there a possibility to develop a structured Taekwondo-based exercise program for adults with musculoskeletal disorders?

Participants will:

* Be a part of the Taekwondo training group or the control group for 12 weeks (where the control group will later participate in the same 12 week Taekwondo for comparison)
* Be assessed within 2 weeks before the start of the training
* Be assessed within 1 week after completing the training

Conditions

Interventions

OTHER

12-week Taekwondo training

12-week structured Taekwondo training program under the supervision of qualified instructors following a standardized protocol. Frequency: 3 sessions per week Session Length: 60 minutes per session

Sponsors & Collaborators

  • Wonju Severance Christian Hospital

    lead OTHER

Principal Investigators

  • Seoung Wan Nam, M.D., Ph.D. · Wonju Severance Christian Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-31
Primary Completion
2025-08-31
Completion
2025-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06823726 on ClinicalTrials.gov